Members of the Carson Lab

 

 

 

ohio-state-logo

 CARSON LAB MEMBERS

 

Dionisia Quiroga, DO, PhD

Breast Medical Oncology Fellow; NIH T32 Post-Doctoral Research Fellow

 

 

  • Undergraduate Institution: Michigan State University
  • Medical School: Michigan State University
  • Graduate School: Michigan State University
  • Residency: Internal Medicine, The Ohio State University Wexner Medical Center
  • Fellowship: Medical Oncology, The Ohio State University Wexner Medical Center

 

 

Dionisia graduated from Michigan State University with her B.S. in physiology in 2007. She was then recruited to MSU’s Medical Scientist Training Program where she completed her medical and graduate school education. Her PhD research focused on the development of recombinant adenoviral vectors as cancer vaccine platforms under the direction of Dr. Andrea Amalfitano. Following completion of medical school, she matched into The Ohio State University’s ABIM Physician Scientist Research Pathway where she completed her internal medicine residency.  Dionisia is currently a PGY-5 breast medical oncology fellow and NIH T32 research fellow in the Carson lab. Her clinical research focuses on the immunologic changes that occur in breast cancer-affected adipose tissue as well as the systemic inflammatory responses to breast cancer-associated lymphedema. Dionisia has been hired to start as a breast medical oncologist and assistant professor in the Division of Medical Oncology at OSU this August 2022 during which she will continue her research studies on breast cancer immunology and immunotherapy.

Debasish Sundi, MD

Assistant Professor, Urology, College of Medicine

 

 

  • Undergraduate Institution: Northwestern University
  • Medical School: Northwestern University, Feinberg School of Medicine
  • Residency: Urology, Johns Hopkins Medical Institutions
  • Fellowship: Urologic Oncology, University of Texas M.D. Anderson Cancer Center

 

 

Dr. Sundi is an expert urologic oncologist who studies bladder cancer. Dr. Sundi’s laboratory employs techniques in basic, translational, and clinical research to model the tumor immune microenvironment of bladder cancer and to optimize outcomes for patients. Dr. Sundi’s past research has been supported by the American Urological Association-Urology Care Foundation. Dr. Sundi’s current laboratory research support includes The Ohio State University Comprehensive Cancer Center, the Naren Patel Genitourinary Cancers Research Fund and grant funding from the U.S. Department of Defense. Active laboratory projects include studies of the bladder immune microenvironment during bladder carcinogenesis and basic/translational studies of sex-differences in bladder cancer immunity and response to immunotherapy. Research activities occur jointly in the Center for Translational Therapeutics and The Pelotonia Institute for Immuno-Oncology (PIIO).

 

Robert Wesolowski, MD

Associate Professor, Division of Medical Oncology

 

  • Undergraduate Institution: Hunter College
  • Medical School: SUNY Downstate Medical Center
  • Residency: Internal Medicine, Cleveland Clinic Foundation
  • Fellowship: Hematology and Oncology, Cleveland Clinic Foundation

 

 

Dr. Wesolowski joined the Division of Solid Tumor Oncology in 2010. His research interests include breast cancer immunology, in particular myeloid-derived suppressor cells (MDSC) and early phase trials of experimental therapeutics. MDSC are important inhibitors of anti-tumor immune response. He studying using MDSC as biomarkers of response to neoadjuvant chemotherapy and recently received a grant supporting this work. He also coordinates phase I solid tumor trials for the Division of Oncology, serves as local principal investigator on several phase I trials and is a member of the Precision Medicine Clinic where cancer patients will have their tumor DNA sequenced to identify cancers with gene mutations that have commercially available drugs that target these gene mutations. Dr. Wesolowski provides clinical care to women with all stages of invasive breast cancer and sees phase I patients in the Precision Medicine Clinic. Click here for his clinical website

 

Himanshu Savardekar, BS

Graduate Student, Biomedical Sciences Graduate Program

 

 

  • Hometown:  Dublin, Ohio
  • Undergraduate Institution: The Ohio State University

 

 

 

 

 

 

Gabriella Lapurga, BS

Research Assistant

 

 

  • Hometown: Chillicothe, OH
  • Undergraduate Institution: The Ohio State University

 

 

 

 

 

Emily Schwarz, BS

Graduate Student, Biomedical Sciences Graduate Program

 

 

  • Hometown: Cleveland, OH
  • Undergraduate Institution:  The Ohio State University

 

 

 

 

 

Emily Fitts, BS

Research Assistant

 

 

  • Hometown:  Fairborn, Ohio
  • Undergraduate Institution:  Cedarville University

 

 

 

 

 

Ruthann Norman, BS

Lab Manager

 

 

  • Hometown: Worthington, Ohio
  • Undergraduate Institution:  Miami University

 

 

 

 

Sara Zelinskas, BS

Research Assistant

 

 

 

  • Hometown: Cincinnati, Ohio
  • Undergraduate Institution: The Ohio State University

 

 

 

 

Colin Angell, BS

Medical Scientist Training Program (G1)

 

 

 

  • Hometown: Midland, MI
  • Undergraduate Institution: The Ohio State University

 

 

 

 

 

Alex Abreo

Undergraduate Research Assistant

 

 

 

 

Hometown: Columbus, OH

Undergraduate Institution:  The Ohio State University

 

 

 

 

 

Erin Hasenoerhl

Undergraduate Research Assistant